The world is awash with data, and while retailers and TV subscription services have perfected the art of collection and curation, public health has been trailing behind.
The COVID-19 pandemic has placed enormous stress on both healthcare systems and researchers, and people all across the sector are looking for digital solutions to help ease the pressure.
Bristol Myers-Squibb and digital health firm GRYT Health have teamed up to develop an ‘Advocacy Exchange’ virtual platform to unite patient advocacy organisations, patients, policy makers,
From AI-driven vaccine candidate selection to the mass roll-out of virtual consultations, digital transformation is accelerating at an unprecedented rate in the face of COVID-19.
Sarepta Therapeutics has decided not to continue the development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy (DMD) therapy Exondys 51.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.